Establishing risk of human experimentation with drugs: lessons from TGN1412.
Kenter
M J H
MJ
Central Committee on Research Involving Human Subjects, The Hague, Netherlands.
Cohen
A F
AF
D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000378:metabolism; D061067:Antibodies, Monoclonal, Humanized; D001709:Biotechnology / Q000639:trends*; D002986:Clinical Trials as Topic / Q000941:ethics / Q000379:methods*; D006805:Human Experimentation; D006801:Humans; D007378:Interleukins / Q000096:biosynthesis; D008253:Macaca mulatta; D008969:Molecular Sequence Data; D018570:Risk Assessment
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007378:Interleukins; C509303:TGN-1412